Insider · CIK 0001360928

Sabella Lauren M

Reports to the SEC for 3 companies · HAWTHORNE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001360928

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-15	MNKDMANNKIND CORPF Tax Payment	EVP Operations	FTax Payment	−11.9K sh	$3.85	−$45.8K	349,841
2025-03-27	MNKDMANNKIND CORPF Tax Payment	EVP Operations	FTax Payment	−16.4K sh	$5.10	−$83.7K	357,849
2024-07-15	MNKDMANNKIND CORPF Tax Payment	EVP Operations	FTax Payment	−1,817 sh	$5.83	−$10.6K	374,256
2024-06-30	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+722 sh	$3.09	+$2,230.98	376,073
2024-05-15	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+129K sh	—	—	375,351
2024-05-15	MNKDMANNKIND CORP · Performance Restricted Stock UnitA Award	EVP Operations	AAward	+158K sh	—	—	158,000
2024-03-27	MNKDMANNKIND CORPF Tax Payment	EVP Operations	FTax Payment	−17.1K sh	$4.63	−$79.1K	246,351
2024-02-04	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+15.3K sh	$3.27	+$50K	263,435
2023-12-31	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+711 sh	$3.09	+$2,196.99	248,145
2023-05-25	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+23.3K sh	—	—	247,434
2023-05-25	MNKDMANNKIND CORP · Performance Restricted Stock UnitA Award	EVP Operations	AAward	+28K sh	—	—	28,000
2023-05-22	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+210K sh	—	—	224,184
2023-05-15	MNKDMANNKIND CORPA Award	EVP Operations	AAward	+14.2K sh	$4.23	+$60K	14,184
2022-09-03	Acorda Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,511 sh	$0.40	−$601.378	10,710
2021-09-03	Acorda Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,511 sh	$4.38	−$6,618.18	12,221
2021-03-03	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+11.1K sh	—	—	13,732
2020-09-17	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+3,015 sh	—	—	15,639
2019-12-02	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,513 sh	$1.60	−$2,421.103	12,624
2019-11-07	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+80K sh	—	—	80,000
2019-03-08	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+9,045 sh	—	—	14,137
2019-03-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+15.1K sh	—	—	15,075
2019-02-22	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−761 sh	$13.18	−$10K	5,092
2018-12-22	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+2,200 sh	—	—	5,853
2018-12-03	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,072 sh	$20.20	−$21.7K	5,687
2018-12-03	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,119 sh	$20.66	−$85.1K	1,568
2018-11-05	Acorda Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−747 sh	$20.28	−$15.1K	6,759
2018-09-10	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+2,200 sh	—	—	7,506
2018-06-28	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,859 sh	$27.84	−$163K	5,306
2018-06-28	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,774 sh	$27.84	−$105K	7,391
2018-06-08	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+24.4K sh	$16.50	+$402K	35,540
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−24.4K sh	$35.00	−$853K	11,165
2018-06-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−24.4K sh	—	—	40,625
2018-05-18	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,288 sh	$23.66	−$172K	11,165
2018-03-08	Acorda Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,085 sh	$25.65	−$53.5K	18,453
2018-02-22	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+5,859 sh	—	—	20,538
2017-12-01	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,670 sh	$20.53	−$34.3K	14,679
2017-05-01	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+65K sh	—	—	65,000
2017-03-01	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+4,400 sh	—	—	16,349
2017-03-01	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+11K sh	—	—	11,000
2016-12-01	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,429 sh	$20.74	−$50.4K	11,949
2016-03-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+27.3K sh	—	—	27,342
2015-12-22	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+7,113 sh	$22.06	+$157K	21,491
2015-12-22	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,113 sh	$42.04	−$299K	14,378
2015-12-22	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−7,113 sh	—	—	9,596
2015-12-17	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+14.2K sh	$22.06	+$314K	28,607
2015-12-17	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−14.2K sh	$40.00	−$569K	14,378
2015-12-17	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−14.2K sh	—	—	16,709
2015-12-01	Acorda Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,106 sh	$38.06	−$270K	14,378
2015-03-04	Acorda Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+6,323 sh	—	—	21,484
2015-03-04	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+35.8K sh	—	—	35,827

Recent filings

Accepted (ET)
Jul 174
Sabella Lauren M0000950170-25-096736
SEC(opens sec.gov)
Mar 284
Sabella Lauren M0000950170-25-047092
SEC(opens sec.gov)
Jul 174
Sabella Lauren M0000950170-24-084407
SEC(opens sec.gov)
May 174
Sabella Lauren M0000950170-24-062065
SEC(opens sec.gov)
Mar 294
Sabella Lauren M0000950170-24-038816
SEC(opens sec.gov)
Feb 54
Sabella Lauren M0001209191-24-002740
SEC(opens sec.gov)
May 264
Sabella Lauren M0001209191-23-032730
SEC(opens sec.gov)
May 244
Sabella Lauren M0001209191-23-032031
SEC(opens sec.gov)
May 154
Sabella Lauren M0001209191-23-029518
SEC(opens sec.gov)
Sep 74
Sabella Lauren M0001209191-22-048948
SEC(opens sec.gov)
Sep 84
Sabella Lauren M0001209191-21-055101
SEC(opens sec.gov)
Mar 54
Sabella Lauren M0001209191-21-018360
SEC(opens sec.gov)
Sep 214
Sabella Lauren M0001209191-20-051241
SEC(opens sec.gov)
Dec 44
Sabella Lauren M0001209191-19-058938
SEC(opens sec.gov)
Nov 124
Sabella Lauren M0001209191-19-055907
SEC(opens sec.gov)
Mar 124
Sabella Lauren M0001209191-19-018797
SEC(opens sec.gov)

Companies

Address

15 SKYLINE DRIVE

HAWTHORNE, NY, 10532